An Antibody Combination That Targets Activated T Cells Extends Graft Survival in Sensitized Recipients
Open Access
- 1 November 2008
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 8 (11), 2272-2282
- https://doi.org/10.1111/j.1600-6143.2008.02393.x
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activitiesBlood, 2006
- Rat Cytomegalovirus Infection Interferes with Anti-CD4 mAb-(RIB 5/2) Mediated Tolerance and Induces Chronic Allograft DamageAmerican Journal of Transplantation, 2006
- Regulatory T cells in transplantationSeminars in Immunology, 2006
- Immunocompetent T-Cells with a Memory-Like Phenotype are the Dominant Cell Type Following Antibody-Mediated T-Cell DepletionAmerican Journal of Transplantation, 2005
- The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challengeInternational Immunology, 2004
- Transplantation tolerance induced by intranasal administration of HY peptidesBlood, 2004
- Selective depletion of activated T cells: the CD40L-specific antibody experienceTrends in Molecular Medicine, 2004
- THE MALE-SPECIFIC HISTOCOMPATIBILITY ANTIGEN, H-Y:A History of Transplantation, Immune Response Genes, Sex Determination and Expression CloningAnnual Review of Immunology, 1997
- The induction of skin graft tolerance in major histocompatibility complex‐mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti‐CD4 and anti‐CD8 antibodiesEuropean Journal of Immunology, 1990
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984